Disease Sciences of Florida is to start the marketing and sale of a range of compounds or super antioxidants which it claims are considerably more potent and effective than conventional antioxidants such as vitamin C and E in lowering the production of free radicals and reducing oxidative stress.
The proprietary compounds, which are sold under the HealthSpan name, also include formulated omega-3 oils that do not cause the digestive side effects which are typical of standard fish-oil supplements, the company said in a statement.
One of the many potential uses of the supplements is the slowing of age-related diseases, Disease Sciences said. Many studies show that antioxidants and omega-3 oils promote cardiovascular health and reduce the risk of degenerative age-related diseases. Disease Sciences plans on building distribution channels through joint marketing agreements, e-commerce and conventional retail sales.
"We are very excited about the prospect of a revenue stream this early in our development," said Dr. Wayne Goldstein, CEO. "A source of revenues will allow us to continue our rapid expansion through further mergers and acquisitions, joint research and drug development activities."
Disease Sciences is a developmental stage biopharmaceutical/clinical diagnostics company whose primary goal is the development of drugs through its subsidiary, HealthSpan Sciences.
HealthSpan is developing small-molecule pharmaceutical products that fight age-related or degenerative diseases by attacking the underlying biochemical origins of degenerative processes. It also plans to create a means of testing for Transmissible Spongiform Encephalopathy (TSE) diseases such as BSE and CJD.